Patients taking generic beta-blockers should check the pharmacy label and call their pharmacist before changing any dose. An Advagen Pharma recall covers metoprolol tartrate 50 mg tablets from one batch, 2611C065A1, in which some bottles may contain tablets or capsules that do not belong in the packaging.
Related: coverage from cruxbuzz.
For context, see Directly similar: Foreign pills in heart medication bottles.
Related: coverage from cruxbuzz.
US patients taking metoprolol tartrate, a beta-blocker prescribed for conditions such as high blood pressure and angina, should check the batch number on the bottle. Advagen Pharma recalled 3,684 bottles of 50 mg metoprolol tartrate from Batch 2611C065A1, and the product was distributed nationwide. Do not stop a beta-blocker suddenly: product labeling warns that abrupt withdrawal can worsen angina or trigger a heart attack.
For context, see Directly similar: Blood pressure medication recall.
| Drug | Identifier | Expiry | Recall concern |
| — | — | — | — |
| Metoprolol tartrate 50 mg | NDC 72888-210-00; Batch 2611C065A1 | May 2028 | Tablets or capsules that do not belong in the packaging |
For context, see Hypertension patient guidance.
## How to verify a pharmacy vial safely
The imprint alone does not confirm whether a tablet is recalled. Ask the pharmacy to check the batch number recorded for the bulk bottle used to fill your prescription. Have the name, strength, prescription number and fill date ready. A pharmacist can say whether your bottle came from the affected batch and tell you how to obtain replacement medicine.
For metoprolol, the concern is that the bottle may contain tablets that are not the labelled medicine. The recall applies to the stated batch, not to every bottle of metoprolol.
**Should I stop taking recalled metoprolol?**
No. Do not stop a beta-blocker on your own. Check whether your bottle is from batch 2611C065A1, then contact your pharmacist or prescriber promptly about replacement, and follow the recall instructions they give you. Sudden withdrawal can cause rebound heart effects, including worsening chest pain.
Suspected product problems can be reported to FDA MedWatch at 1-800-332-1088. The recall described here concerns US distribution; patients outside the US should use their local regulator and pharmacy channels.
—